Grünenthal GmbH: Chronic Pain trials

The registry lists 10 Chronic Pain studies with Grünenthal GmbH as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 1 2Phase 2 1Phase 3 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Tapentadol in Chronic Malignant Tumour Related PainTerminatedNCT01264887Phase 3Results posted
• Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of TolerabilityTerminatedNCT00986258Phase 3Results posted
• Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular AnalgesicsCompletedNCT00983385Phase 3Results posted
• Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking Either WHO Step I or Step II Analgesics or no Regular AnalgesicCompletedNCT00983073Phase 3Results posted
• Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking WHO Step III Analgesics But Showing a Lack of Tolerability.TerminatedNCT00982280Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the KneeCompletedNCT00486811Phase 3Results posted
• A Clinical Study in Healthy Women Which Aims to Explore the Intestinal Uptake of Two Different Tablets of GRTA9906 Into the Body and the Effect of Food on itCompletedNCT03765801Phase 1
• A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure to Investigate the Safety and Tolerability of GRT0151Y and to Find Out Which Single Dose of the Compound is Maximally ToleratedCompletedNCT03765658Phase 1
• Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve PainCompletedNCT01752322Phase 3
• Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative PainTerminatedNCT01155986Phase 2